Document is current
Any future updates will be listed below
-
Authors
Bischof, Helmut https://orcid.org/0000-0003-2380-600X
Rehberg, Markus
Stryeck, Sarah
Artinger, Katharina
Eroglu, Emrah https://orcid.org/0000-0002-9373-0808
Waldeck-Weiermair, Markus
Gottschalk, Benjamin
Rost, Rene
Deak, Andras T.
Niedrist, Tobias
Vujic, Nemanja
Lindermuth, Hanna
Prassl, Ruth https://orcid.org/0000-0002-1010-9494
Pelzmann, Brigitte
Groschner, Klaus
Kratky, Dagmar https://orcid.org/0000-0003-1357-7573
Eller, Kathrin
Rosenkranz, Alexander R.
Madl, Tobias https://orcid.org/0000-0002-9725-5231
Plesnila, Nikolaus https://orcid.org/0000-0001-8832-228X
Graier, Wolfgang F. https://orcid.org/0000-0003-1871-3298
Malli, Roland
- License Information
-
More Information
Article History
Received: 10 July 2017
Accepted: 4 October 2017
First Online: 10 November 2017
Competing interests
: Together with the legal representatives of the Medical University of Graz () the inventors of GEPIIs and authors of this paper, H.B., E.E., W.F.G., R.M., and M.W.-W. have filed a patent application at the Austrian patent office () with the application number A50400/2017. Purified GEPIIs and plasmids coding for GEPIIs mentioned in this manuscript are commercially available upon request at Next Generation Fluorescence Imaging (NGFI) GmbH (), a private spin-off company of the Medical University of Graz. E.E., W.F.G., R.M., and M.W.-W. are shareholders of NGFI. The remaining authors declare no competing financial interests.
